Patient Guide: A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 112 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04712097
Status: ACTIVE_NOT_RECRUITING
Condition: Relapsed or Refractory Follicular Lymphoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 112 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • Atlanta, Georgia
  • Fort Wayne, Indiana
  • • And 109 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily